中文名稱:Sabatolimab | 英文名稱:Research Grade Sabatolimab(DHJ28402) |
CAS:2252262-24-9 | 純度規(guī)格: PAGE:>95% |
產(chǎn)品類別: 藥物對照抗體 | |
抗體名: Sabatolimab | 靶點: T-cell immunoglobulin mucin receptor 3, HAVcr-2, TIMD-3, T-cell membrane protein 3, HAVCR2, Hepatitis A virus cellular receptor 2, CD366, TIMD3, TIM-3, TIM3, T-cell immunoglobulin and mucin domain-containing protein 3 |
宿主: Humanized | 適應(yīng)物種: Human |
克隆性: Monoclonal | 藥物對照抗體: Sabatolimab |
Tags:Sabatolimab 代理商,Sabatolimab 價格,Sabatolimab 供應(yīng)商, Sabatolimab supplier,Sabatolimab purchase,Sabatolimab 購買,Sabatolimab 銷售
Catalog No.
DHJ28402
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1.56 mg/ml
Purity
>95%
Clonality
Monoclonal
Isotype
IgG4-kappa
Applications
Research Grade Biosimilar
Target
T-cell immunoglobulin mucin receptor 3, HAVcr-2, TIMD-3, T-cell membrane protein 3, HAVCR2, Hepatitis A virus cellular receptor 2, CD366, TIMD3, TIM-3, TIM3, T-cell immunoglobulin and mucin domain-containing protein 3
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
Q8TDQ0
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
MBG-453, CAS: 2252262-24-9
Note
For research use only. Not suitable for clinical or therapeutic use.
成立日期 | 2021-04-08 (4年) | 注冊資本 | 一千萬元人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥1570 |
VIP3年
|
TargetMol中國(陶術(shù)生物)
|
2024-12-12 | |
¥8599.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 |